Skip to content

Orchestra BioMed Holdings, Inc.

OBIO

CIK 0001814114

← back to feed
Revenue (TTM)
$2.68M
+1,169.2% YoY Q1 May 2026
Net Income (TTM)
−$79.64M
+13.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.72
+33.1% YoY Q1 May 2026
Gross Margin
93.6%
Q1 May 2026
Operating Margin
-3,014.5%
Q1 May 2026
Net Margin
-2,977.1%
Q1 May 2026
Free Cash Flow (TTM)
−$66.62M
Q1 May 2026
Cash
$28.37M
Q1 May 2026
Total Debt
$15M
Q1 May 2026
Shares Outstanding
59.88M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings